Drug Dealing and Brokering Lawyer
Drug Dealing and Brokering Lawyer | What Determines Your Sentence, and How to Challenge It
Selling or brokering drugs is treated far more seriously under Korean law than simple possession or use, because the Act on Control of Narcotics, etc. (마약류관리에관한법률) and the Act on Special Cases Concerning the Confiscation and Return of Illicit Profits from Narcotics-Related Crimes (마약류불법거래방지법) impose escalating penalties based on the type of drug, the conduct involved, and the defendant's role. A single act of sale can trigger a minimum sentence of imprisonment with no option for a fine, and for-profit or repeat trafficking can lead to life imprisonment or the death penalty in extreme cases. Whether you are charged as the actual seller, a broker who merely connected buyer and seller, or someone swept into a group investigation as a 'co-conspirator,' the specific role you played is often the single biggest factor a court will weigh. Because these cases usually start with an arrest and rapid indictment, early legal strategy on evidence and role characterization matters more than in most other criminal cases.
Drug Dealing and Brokering | How the Law Classifies Dealing and Brokering
The Act on Control of Narcotics, etc. (마약류관리에관한법률) does not treat all 'trafficking' the same way. The charge you face depends on the type of narcotic, the quantity, and whether your conduct is classified as manufacture, import, sale, or brokering.
Manufacturing, importing, or selling narcotics (excluding cannabis in some sub-clauses) carries imprisonment for at least 5 years, and if done for profit or habitually the statute allows for death, life imprisonment, or at least 10 years (마약류관리에관한법률 제58조). Even a single completed sale, without any prior record, is charged under this article and a fine-only outcome is not available.
Selling or brokering psychotropic substances (향정신성의약품), which covers many commonly abused synthetic drugs, is punished according to the substance's schedule: life imprisonment or at least 5 years for Schedule Ga (가목) substances, and up to 10 years' imprisonment or a fine of up to KRW 100 million for Schedule Na and Da (나목·다목) substances (마약류관리에관한법률 제58조 제1항 제3호, 제60조 제1항 제2호). Brokering — connecting a buyer and seller without personally handling the drugs — is treated under the same article as direct sale.
Sale or brokering of cannabis is punished by imprisonment for at least one year, with no fine-only option, and habitual offenses carry at least three years (마약류관리에관한법률 제59조 제1항 제7호, 제2항).
For sales of psychotropic substances, the Act on the Aggravated Punishment of Specific Crimes sets thresholds based on the value of the drugs involved (KRW 5 million and KRW 50 million), not their weight, above which the applicable minimum sentence rises sharply (특정범죄가중처벌등에관한법률 제11조 제2항). Prosecutors often calculate quantity by combining multiple smaller transactions over time, which is frequently the first point worth disputing.
Beyond imprisonment, courts can order confiscation of the drugs themselves and of profits or property traceable to the sale under the Act on Special Cases Concerning the Confiscation and Return of Illicit Profits from Narcotics-Related Crimes (마약류불법거래방지법). This can extend to bank records and property unrelated on their face to the specific transaction charged.
Fine-Only Resolution Is Rarely Available
Unlike many other offenses, sale or brokering under Articles 58-60 generally does not permit a fine as an alternative to imprisonment once a court finds the charge proven, though a suspended sentence remains possible depending on quantity, role, and prior record. This is why disputing the classification of your conduct (sale vs. brokering vs. mere use) and the quantity attributed to you is central to defense strategy.
Drug Dealing and Brokering | Why Quantity Changes Everything
In drug dealing cases, the single most consequential fact is often not whether you sold drugs, but how much the prosecution attributes to you. Small differences in quantity calculation can move a case from a suspended sentence to a mandatory multi-year term.
How Prosecutors Calculate 'Quantity'
Investigators frequently aggregate every transaction they can trace to a suspect over months, including transactions proven only through co-defendant statements or phone records, not just the amount seized at arrest. Whether each alleged transaction is separately provable, and whether aggregation across time is legally appropriate, is a key point to examine with defense counsel.
Value Thresholds and Their Practical Effect
Once the value of psychotropic substances sold reaches the statutory thresholds (KRW 5 million and KRW 50 million), the applicable minimum sentence jumps sharply and the case may be prosecuted under the Act on the Aggravated Punishment of Specific Crimes rather than as an ordinary sale (특정범죄가중처벌등에관한법률 제11조 제2항). Challenging the purity, weight measurement, or the number of separate acts counted can meaningfully affect which threshold applies.
Prior Record and Repeat Offense Enhancement
A prior narcotics conviction, even an old or minor one, can trigger repeat-offender enhancement provisions that raise both the statutory minimum and the range courts typically apply in practice. Distinguishing a prior simple-use conviction from a prior sale conviction matters for how much enhancement actually applies.
Drug Dealing and Brokering | Seller, Broker, or Bystander — Why the Label Matters
Korean narcotics law and sentencing practice draw real distinctions between the person who profited from a sale, the person who merely introduced a buyer to a seller, and someone who was present or assisted without direct financial gain. These distinctions are often contested at trial.
Distinguishing 'Sale' from 'Brokering'
A seller is someone who has possession or control of the drug and transfers it in exchange for payment; a broker merely arranges or facilitates the transaction between others (마약류관리에관한법률 제58조 제1항, 제59조 제1항 제7호, 제60조 제1항 제2호). Both are punished under the same article, but courts have historically weighed a broker's lack of direct profit and lack of possession as a mitigating factor in sentencing within the applicable range.
'Simple Use' vs. 'Sale' When Drugs Change Hands Without Payment
Sharing drugs with a friend without payment, or purchasing on someone else's behalf purely for shared personal use, can sometimes be argued as joint possession or use rather than sale, which carries a materially different sentencing range. Whether money or any benefit-in-kind changed hands is central to this distinction, and it is frequently the first fact investigators focus on.
Entrapment and Controlled Buy Issues
Some cases originate from undercover purchases or informant-arranged transactions. Whether the investigative method crossed from legitimate undercover investigation into impermissible inducement (entrapment) can, in limited circumstances, affect the admissibility of evidence or the characterization of the defendant's role.
Drug Dealing and Brokering | Disputing Co-Conspirator Liability
Drug distribution networks are usually investigated and prosecuted as a group, and prosecutors often seek to hold every participant liable for the full scope of the network's activity, not just each person's individual acts. This is one of the most fertile grounds for defense in multi-defendant narcotics cases.
Co-Principal vs. Aiding and Abetting
Under general criminal law principles, being charged as a co-principal (공동정범) requires proof of a shared intent and functional role in the crime, not merely awareness that a crime was occurring nearby (형법 제30조). A person who, for example, only lent a phone or a room without knowledge of the specific transaction may have grounds to argue for aiding and abetting liability (형법 제32조) or no liability at all, which carries a lighter sentencing range.
Attributing a Co-Defendant's Total Sales to You
When one member of a network is proven to have sold a large cumulative quantity, prosecutors sometimes attempt to attribute that entire quantity to every co-defendant on a conspiracy theory. Whether the evidence actually shows you shared in the profits or decision-making for the full scope of the operation, rather than only your own discrete acts, is a central question that can significantly change your exposure.
Reliability of Co-Defendant Statements
Many multi-defendant narcotics cases rely heavily on statements co-defendants gave investigators, often made under the incentive of receiving more lenient treatment for cooperating. Cross-examining the consistency, timing, and motive behind such statements is frequently a key part of trial strategy.
Drug Dealing and Brokering | From Arrest or Summons to Resolution
We review the facts known so far — how the investigation started, what was seized, and what statements have already been given — to identify early which role and quantity issues are likely to be contested.
Most narcotics cases involve custodial or non-custodial interrogation, urine and hair testing, and phone/financial record review. Decisions made at this stage about what to say and what not to say often shape the entire case.
If prosecutors seek pretrial detention, a judge holds a hearing on whether detention is warranted. Arguing against detention early can materially affect how the rest of the case is handled, including plea and sentencing negotiations.
Once indicted, we examine the prosecution's evidence file for how quantity was calculated, how co-defendant statements were obtained, and whether the charge (sale, brokering, or use) matches the actual conduct proven.
At trial, contested issues typically include quantity aggregation, role classification, and mitigating factors such as rehabilitation efforts, lack of prior record, and cooperation with treatment programs.
Drug Dealing and Brokering | How Fees Are Set in Drug Dealing Cases
Generally set based on the stage of the case (pre-indictment investigation, detention review, or trial), the number of charges involved, and whether the case involves multiple co-defendants requiring coordinated defense.
If used, tied to a clearly defined and lawful outcome such as avoiding detention, a non-prosecution decision, or a reduction from an indicted charge — never framed as a guarantee of acquittal or a specific sentence, which would be inconsistent with attorney advertising rules.
Representation at a detention review hearing is often billed separately from general investigation-stage representation because of its urgency and the short preparation window involved.
Costs such as document procurement, expert review of drug test methodology, and travel for detention facility visits are billed separately from the retainer.
※ Costs vary depending on case complexity and specific circumstances; exact fees will be provided during consultation. No specific outcome is guaranteed.
Drug Dealing and Brokering | Self-Check Before You Speak to Investigators
1️⃣ If You Have Just Been Contacted or Summoned
- Have you been told whether you are being investigated as a suspect (피의자) or only as a witness?
- Do you know exactly what quantity or number of transactions investigators are asking about?
- Have you already made any statement to police, in person or by phone, before consulting a lawyer?
- Do you know whether a family member or co-defendant has already given a statement naming you?
2️⃣ If You Are Facing a Detention Review
- Do you have a fixed address and stable living situation you can document?
- Is this your first narcotics-related charge, or do you have a prior record?
- Can you show any steps already taken toward treatment or rehabilitation?
- Do you have anyone who can support an argument that you are not a flight risk?
3️⃣ If You Are Charged as a Broker Rather Than a Seller
- Did you ever personally possess or hold the drugs at any point?
- Did you receive any payment, discount, or benefit-in-kind for connecting buyer and seller?
- Do phone or messaging records show the actual negotiation, or only that you were present in a group chat?
4️⃣ If You Are One of Several Co-Defendants
- Does the indictment attribute a co-defendant's total sales quantity to you as well?
- Can you identify which specific acts, dates, or amounts are actually tied to you individually?
- Do you know what statements other co-defendants have given about your role?
